Sort
39,280 grants matching “leukemia”
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
$322,040Markus Mãschen · Children'S Hospital Of Los Angeles · R01 · FY2012 · CA
Targeting non-classical oncogenes as therapy for T-ALL
$322,040Thomas G. Diacovo · Columbia University Health Sciences · R01 · FY2014 · CA
Interferon Responses in Myeloid Leukemia
$322,040Serge Y Fuchs · University Of Pennsylvania · R01 · FY2012 · CA
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
$322,040Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2014 · CA
Interferon Responses in Myeloid Leukemia
$322,040Serge Y Fuchs · University Of Pennsylvania · R01 · FY2011 · CA
A Phase I/II Trial of Eltrombopag in Elderly Acute Myeloid Leukemia Patients
$322,040Martin Carroll · University Of Pennsylvania · R21 · FY2011 · CA
Pre-B cell receptor signaling in acute lymphoblastic leukemia
$322,040Markus Mãschen · Children'S Hospital Of Los Angeles · R01 · FY2011 · CA
Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis
$322,040Christopher Joachim Lengner · University Of Pennsylvania · R01 · FY2014 · CA
Mechanism of action of Prdm16 in hematopoietic stem cells
$322,040Hans-Willem E Snoeck · Columbia University Health Sciences · R01 · FY2014 · CA
The role of PHF6 in T-cell acute lymphoblastic leukemia
$322,040Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2014 · CA
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
$322,040Markus Mãschen · Children'S Hospital Of Los Angeles · R01 · FY2011 · CA
Improving the disposition of antileukemic asparaginase after drug-induced immunotoxicity
$322,023Christian Antonio Fernandez · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
Molecular mechanisms of transcriptional regulation in the Notch pathway
$322,001Rhett Kovall · University Of Cincinnati · R01 · FY2013 · CA
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
$322,000Bryan R. Cullen · Duke University · R01 · FY2020 · DA
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
$322,000Bryan R. Cullen · Duke University · R01 · FY2021 · DA
LSUHSC-Shreveport Feist-Weiller Cancer Center MBCCOP
$322,000Glenn M Mills · Louisiana State Univ Hsc Shreveport · U10 · FY2007 · CA
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
$322,000Bryan R. Cullen · Duke University · R01 · FY2022 · DA
MOUSE MODELS FOR FAMILIAL PLATELET DISORDER
$321,975Dartmouth College · R01 · FY2001 · CA
Development of small molecule inhibitor of Mcl-1 for cancer treatment
$321,958Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2011 · CA
Cooperating genes in inv (16) acute myeloid leukemia
$321,949Lucio H. Castilla · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · CA
(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies
$321,937Kristy L Richards · Cornell University · R01 · FY2016 · CA
Histone Deacetylase Inhibitors in CML
$321,925H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2005 · CA
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
$321,912Konstantin H. Dragnev · Dartmouth-Hitchcock Clinic · UG1 · FY2020 · CA
Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment
$321,898Elise C. Kohn · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Regulation of Chemokine Mediated Leukocyte Functions
$321,870Micheler Ricardo Richardson · North Carolina Central University · R01 · FY2008 · AI